The characteristics of basolateral nucleoside transport in the perfused sheep choroid plexus and the effect of nitric oxide inhibition on these processes.
The single pass paired dilution technique was used to measure the uptake of nucleosides across the basolateral face of the isolated in situ perfused sheep choroid plexus (CP). The uptake of labelled adenosine and guanosine into the CP was large (approximately 35%) whereas that of thymidine was less (approximately 15%). The addition of 0.5 mM unlabelled adenosine to the perfusate inhibited the uptake of labelled adenosine by 66%, guanosine by 100% and that of thymidine by 50%, whereas the addition of 0.5 mM unlabelled thymidine caused complete self-inhibition. The backflux of adenosine was very small which may indicate a high rate of cellular metabolism or a flux into cerebrospinal fluid (CSF). The addition of 0.5 mM unlabelled adenosine did not alter the backflux of adenosine, but increased that of guanosine and thymidine. The entry of radioactivity derived from adenosine across the apical side of the CP cells into the newly formed CSF was determined as a 'CSF uptake index' relative to [14C]butanol and found to be about 25%; however, HPLC analysis revealed that the majority of this activity was hypoxanthine, and not adenosine. The complete inhibition of nitric oxide synthase caused a significant reduction in adenosine uptake into the CP and an increase in backflux for this molecule. It would appear that the uptake for adenosine by the CP is governed by the rate of cellular metabolism and not by the rate of transport into the cells of the choroid plexus whereas for guanosine and thymidine, transport is of greater importance.
Redzić
Z B
ZB
Institute of Biochemistry, School of Medicine, Belgrade, Yugoslavia.
Segal
M B
MB
Marković
I D
ID
Gasić
J M
JM
Vidović
V
V
Rakić
L M
LM
D000241:Adenosine / Q000493:pharmacokinetics; D000818:Animals; D001692:Biological Transport; D002831:Choroid Plexus / Q000378:metabolism*; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D006151:Guanosine / Q000493:pharmacokinetics; D019331:NG-Nitroarginine Methyl Ester / Q000494:pharmacology; D019001:Nitric Oxide Synthase / Q000037:antagonists & inhibitors*; D009705:Nucleosides / Q000493:pharmacokinetics*; D010477:Perfusion; D012756:Sheep; D013936:Thymidine / Q000493:pharmacokinetics
D004791:Enzyme Inhibitors; D009705:Nucleosides; D006151:Guanosine; D019001:Nitric Oxide Synthase; D000241:Adenosine; D019331:NG-Nitroarginine Methyl Ester; D013936:Thymidine